Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Combination therapy is typically considered for patients with inadequate glycemic control on GLP-1 monotherapy or when cost, adherence, or side effects favor adding an oral DPP-4 rather than increasing GLP-1 dose
The key difference lies in tax efficiency: FSA and HSA payments avoid federal income tax, effectively reducing the net cost of treatment for eligible account holders
If irritation persists or worsens, contact your pharmacy about alternative formulation options
For a 220-pound person, thats approximately 33 pounds lost over 16 months
Europe sets out to reform its clinical trial rules
Approved for type 2 diabetes management
US$ 23.02
US$ 28.23
US$ 23.23
US$ 20.87
US$ 25.37
US$ 29.75
US$ 27.37
US$ 22.32
US$ 29.62
US$ 25.86
